{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:23:50Z","timestamp":1792121030917,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK, United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health, United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research (NIHR) Cancer Research Network, United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012139","name":"Royal Marsden NHS Foundation Trust, United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000027","name":"Institute of Cancer Research, Portugal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000348","name":"Calouste Gulbenkian Foundation, Portugal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000348","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia, Portugal"},{"name":"Champalimaud Foundation, Portugal"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clon.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T22:05:27Z","timestamp":1553033127000},"page":"374-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-5815","authenticated-orcid":false,"given":"M.R.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Truelove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3954-2806","authenticated-orcid":false,"given":"D.P.","family":"Dearnaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gulliford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2019.02.012_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6004\/jnccn.2016.0004","article-title":"NCCN clinical practice guidelines in oncology: prostate cancer","volume":"14","author":"Mohler","year":"2016","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clon.2019.02.012_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrurol.2015.25","article-title":"Radiotherapy for high-risk prostate cancer","volume":"12","author":"Mohiuddin","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clon.2019.02.012_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ijrobp.2017.07.041","article-title":"A\u00a0phase 1\/2 dose escalation study of the use of intensity modulated radiotherapy (IMRT) to treat the prostate and pelvic nodes in patients with prostate cancer","volume":"99","author":"Reis Ferreira","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/gut.2004.062596","article-title":"Gastrointestinal complications of pelvic radiotherapy: are they of any importance?","volume":"54","author":"Andreyev","year":"2005","journal-title":"Gut"},{"issue":"Suppl","key":"10.1016\/j.clon.2019.02.012_bib5","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.radonc.2013.10.021","article-title":"Dose\/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions","volume":"109","author":"Thor","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1748-717X-9-129","article-title":"Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy","volume":"9","author":"McDonald","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jrr\/rru080","article-title":"Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer","volume":"56","author":"Someya","year":"2014","journal-title":"J\u00a0Radiat Res"},{"issue":"Suppl","key":"10.1016\/j.clon.2019.02.012_bib9","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel","volume":"76","author":"Kavanagh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib10","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1088\/0031-9155\/57\/5\/1399","article-title":"Late rectal bleeding after 3D-CRT for prostate cancer: development of a neural-network-based predictive model","volume":"57","author":"Tomatis","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2019.02.012_bib11","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1088\/0031-9155\/58\/8\/2581","article-title":"Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy","volume":"58","author":"Acosta","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2019.02.012_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1470-2045(11)70302-3","article-title":"Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study","volume":"13","author":"Barnett","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib14","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib15","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0360-3016(86)90279-8","article-title":"A\u00a0prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation","volume":"12","author":"Gallagher","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0360-3016(00)01414-0","article-title":"Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms","volume":"49","author":"Jackson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(02)00147-0","article-title":"Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions","volume":"64","author":"Fiorino","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib18","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ijrobp.2004.12.087","article-title":"Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?","volume":"62","author":"Andreyev","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0360-3016(95)90159-0","article-title":"Lent soma scales for all anatomic sites","volume":"31","year":"1995","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00005650-199807000-00007","article-title":"The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure","volume":"36","author":"Litwin","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.clon.2019.02.012_bib22","first-page":"65","article-title":"A\u00a0simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1016\/j.clon.2019.02.012_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijrobp.2015.07.2263","article-title":"Evaluation of the risk of grade 3 oral and pharyngeal dysphagia using atlas-based method and multivariate analyses of individual patient dose distributions","volume":"93","author":"Otter","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib24","volume":"vol. 1","author":"R Development Core Team R","year":"2011"},{"key":"10.1016\/j.clon.2019.02.012_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ijrobp.2016.11.008","article-title":"Acute and late adverse events associated with radical radiation therapy prostate cancer treatment: a systematic review of clinician and patient toxicity reporting in randomized controlled trials","volume":"97","author":"Holch","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib26","series-title":"Basic clinical radiobiology","article-title":"The linear-quadratic approach in clinical practice","author":"Bentzen","year":"2009"},{"key":"10.1016\/j.clon.2019.02.012_bib27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2009.02.025","article-title":"Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397","volume":"76","author":"Gulliford","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib29","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ijrobp.2007.07.2354","article-title":"Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study","volume":"70","author":"Fiorino","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib30","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib31","series-title":"Basic clinical radiobiology","year":"2009"},{"key":"10.1016\/j.clon.2019.02.012_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2008.10.086","article-title":"Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer","volume":"75","author":"Fiorino","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.02.012_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.radonc.2010.02.025","article-title":"Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy","volume":"97","author":"Perna","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib34","doi-asserted-by":"crossref","first-page":"143020","DOI":"10.1155\/2014\/143020","article-title":"The different dose-volume effects of normal tissue complication probability using lasso for acute small-bowel toxicity during radiotherapy in gynecological patients with or without prior abdominal surgery","volume":"2014","author":"Lee","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clon.2019.02.012_bib35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.adro.2017.09.005","article-title":"Late small bowel toxicity after aggressive abdominopelvic intensity modulated radiation therapy","volume":"2","author":"Ling","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib36","first-page":"411","article-title":"Dose-volume relationship of acute and late small bowel toxicity from radiation therapy for prostate cancer: a Veterans Affairs study","volume":"4","author":"Green","year":"2015","journal-title":"J\u00a0Radiat Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.radonc.2011.06.032","article-title":"Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer","volume":"100","author":"Rancati","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2014.02.012","article-title":"A\u00a0genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity","volume":"111","author":"Barnett","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2019.02.012_bib39","doi-asserted-by":"crossref","first-page":"PE139","DOI":"10.1016\/S1470-2045(13)70504-7","article-title":"Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist","volume":"15","author":"Reis Ferreira","year":"2014","journal-title":"Lancet Oncol"},{"issue":"6 Suppl","key":"10.1016\/j.clon.2019.02.012_bib40","doi-asserted-by":"crossref","first-page":"1203S","DOI":"10.1093\/ajcn\/55.6.1203S","article-title":"Changes in gastrointestinal function attributed to aging","volume":"55","author":"Russell","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clon.2019.02.012_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/gut.28.3.353","article-title":"Effect of aging on anorectal function","volume":"28","author":"Bannister","year":"1987","journal-title":"Gut"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519300913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519300913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:46:04Z","timestamp":1760543164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655519300913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0936655519300913"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2019.02.012","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}